Commerce and Industry Ministry considering proposal for compulsory license to anti-cancer drug
Advertisement
NEW DELHI: Commerce and Industry Ministry is considering a proposal of the health ministry for grant of compulsory license (CL) to an anti-cancer drug - Dasatinib, Parliament was informed today.The ministry has received a proposal from the Ministry of Health and Family Welfare for grant of CL in respect of the drug.
Under the Indian Patents Act, a compulsory License can be issued for a drug if the medicine is deemed unaffordable by the government and grants permission to qualified generic drug makers to manufacture it.
Commerce and Industry Minister Nirmala Sitharaman said the matter was examined and accordingly the Health Ministry was requested to furnish full particulars in respect of existence of circumstances of - national emergency; or extreme urgency; or a case of public non-commercial use, as required under Section 92 of the Patents Act 1970.
"The reply by the Department of Health and Family Welfare is under active consideration of this department," Sitharaman said in a written reply to the Lok Sabha.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.